Adults 18 to 80 years of age may qualify for a study evaluating an investigational treatment for irritable bowel syndrome with diarrhea (IBS-D) or irritable bowel syndrome with mixed bowel habits (IBS-M). Participants in this study must have a diagnosis of IBS-D or IBS-M and symptoms including abdominal pain.